Samantha E. Duarte

Internal Medicine | Hospital Medicine

251 E Huron St
Chicago, IL 60611

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 5 publications

Fine mapping and candidate gene analysis of a dravet syndrome modifier locus on mouse chromosome 11.

Fine mapping and candidate gene analysis of a dravet syndrome modifier locus on mouse chromosome 11.

Journal: Mammalian genome : official journal of the International Mammalian Genome Society

Published: March 18, 2022

Response to Nivolumab and Ipilimumab in Microsatellite Instability-High (MSI-H) Cervical Carcinoma with Acquired Resistance to Pembrolizumab: A Case Report and Literature Review.

Response to Nivolumab and Ipilimumab in Microsatellite Instability-High (MSI-H) Cervical Carcinoma with Acquired Resistance to Pembrolizumab: A Case Report and Literature Review.

Journal: The oncologist

Published: October 09, 2021

Artificial Intelligence-based Radiomics in the Era of Immuno-oncology.

Artificial Intelligence-based Radiomics in the Era of Immuno-oncology.

Journal: The oncologist

Published: August 05, 2021

Soticlestat, a novel cholesterol 24-hydroxylase inhibitor, reduces seizures and premature death in Dravet syndrome mice.

Soticlestat, a novel cholesterol 24-hydroxylase inhibitor, reduces seizures and premature death in Dravet syndrome mice.

Journal: Epilepsia

Published: May 27, 2021

Gabra2 is a genetic modifier of Dravet syndrome in mice.

Gabra2 is a genetic modifier of Dravet syndrome in mice.

Journal: Mammalian genome : official journal of the International Mammalian Genome Society

Published: March 16, 2021

Showing 1-5 of 5

Last Updated: 09/26/2026